Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.
about
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingInfluence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexiaDistinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trialHome parenteral nutrition in advanced cancer: where are we?Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trialInfluence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet.Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.Clinical anticachexia treatments.Clinical development of ghrelin axis-derived molecules for cancer cachexia treatmentComputational modeling of cancer cachexia.One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trialNutrition modulation of cachexia/proteolysis.Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.Cancer cachexia: mechanisms and clinical implications.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatmentAn Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.Interleukin 6 as a key regulator of muscle mass during cachexiaIntramyocellular lipid droplets increase with progression of cachexia in cancer patientsNutritional status of patients with locally advanced pancreatic cancer: a pilot study.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary diseaseSkeletal muscle atrophy is attenuated in tumor-bearing mice under chemotherapy by treatment with fish oil and selenium.Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.Research methodology: cancer cachexia syndrome.Multifocal angiostatic therapy: an update.Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.Marine polyunsaturated fatty acids and cancer therapyThe emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingDietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic micePlasma polyunsaturated fatty acids and age-related physical performance decline.Energy metabolism and nutritional status in hospitalized patients with lung cancerMuscle function and omega-3 fatty acids in the prediction of lean body mass after breast cancer treatment.Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19Potential applications of fish oils rich in n-3 fatty acids in the palliative treatment of advanced pancreatic cancer.Nutrition and physical activity guidelines for cancer survivors.
P2860
Q26781640-7F6C9422-15E9-49FF-A407-69140B98DC9CQ26827510-270652F3-D91C-4D88-9E0B-5AA55FB888BFQ28542391-4D938B87-36AD-4A41-AE1D-CF0D3B779C82Q30667879-521883C7-03FB-4331-B00E-A11C22515704Q31149845-9A0B8028-5428-49C0-ADBC-5A4F8110B244Q33755930-63FED611-3588-466A-B93F-4CB3DBAD0E98Q33976122-C933B6A3-2198-49C9-8F93-48F56E332B94Q33991186-0F11519C-2BFC-4A4E-AAA3-D1A89AC6485FQ33994400-585D1481-60A5-432E-A29D-9F3823F669DEQ34002674-2A05C8E6-E10C-49CA-A595-9314BF8384BCQ34011017-726C079D-9854-41E9-B3F9-D811DD77A25CQ34034275-D99E50D7-B1C2-4494-B8E4-A414AE3F92D1Q34210506-A7264D58-BEB8-4385-A9D8-E8DEA7DBE7EEQ34236379-305D2419-D392-42B3-8D00-140B72DA42CCQ34354878-2BAB296D-182F-417C-9195-5592594A6834Q34565917-7CE72FDD-7A27-4F23-88D6-74DC93AF5FE1Q34583647-CA6C6CC3-068F-4C58-AE79-2743C8D5F6ADQ34631019-D7C7D47B-C1C4-43CA-9A81-BD9ECAA32CF9Q34660312-595B6AB7-E49E-4F31-B4B8-32D2E540F469Q34669440-44801DCC-643A-4205-8D4B-5002EE161F12Q34672667-6EC79D8E-1ED0-47DE-B5B2-7895FF001A2BQ34727530-58751DDF-9584-4122-905D-535E64C7CAD2Q35053586-E87CBCE5-A075-445E-94E6-EEFF75CDC4FCQ35112838-D7B589B6-C2EA-4C1F-A573-573054E91AC6Q35122201-26473A39-F83A-485D-BD1F-0A7506521697Q35564212-B4175577-791E-4EDB-B265-507C1C6A4BCBQ35781409-F41E6324-015C-43FC-BF30-C22D7E009FB3Q35828425-638412D4-91C4-4986-8DE5-8E6E35CE049DQ35872798-F3BAACE9-0CD2-46E3-8B6E-912F85139378Q36311166-FCC56E34-2FA8-4CAE-B3E2-EE54ADEBD31DQ36520744-E9075FB7-EE02-481D-AE7A-9ABD7993C7F9Q36671846-D7BED203-9EA0-41F9-8F5B-5DBB90F5429BQ36901945-818A8C2E-2C3F-4E76-ADCF-4DC1FAAEEB5AQ37123496-E19EA9CD-64D2-4EA5-B55B-31233F3D30E4Q37171906-102E4764-A632-498A-8C33-64A6EE73F070Q37247027-D503109B-4C59-4CBA-A36D-F712513AF012Q37439648-D8096723-21E1-4734-8DF8-FD59C95AD11BQ37667893-039BB40F-43AF-431E-BEFA-39EE907EF25DQ37899960-8D1B5AEA-6FE8-4362-997F-17EF31994B2DQ38005959-80AFA736-737D-469A-A5D7-9ADDFBC06F46
P2860
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@ast
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@en
type
label
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@ast
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@en
prefLabel
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@ast
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@en
P2093
P2860
P356
P1476
Reduced total energy expenditu ...... enriched with n-3 fatty acids.
@en
P2093
A W G Moses
K C H Fearon
M D Barber
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601620
P407
P577
2004-03-01T00:00:00Z
P5875
P6179
1000499073